PDL BioPharma, Inc. (Nasdaq: PDLI) has entered into a settlement with MedImmune, LLC.
This article: 64 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE